Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Colleen Anne Maher"'
Autor:
Phillip Wong, Dean F. Bajorin, Katherine S. Panageas, Michael A. Postow, Travis J. Hollmann, Ronglai Shen, Taha Merghoub, Colleen Anne Maher, Allison S. Betof, Parisa Momtaz, Jedd D. Wolchok, Paul B. Chapman, Alexander N. Shoushtari, Hikmat Al-Ahmadie, Samuel A. Funt, Michael A. Curran, Gopa Iyer, Jonathan E. Rosenberg, Niamh M. Keegan, Margaret K. Callahan, Liwei Jia, Arshi Arora, Margaret Hannum, Matthew Adamow
Publikováno v:
Sci Transl Med
Immune checkpoint blocking antibodies are a cornerstone in cancer treatment; however, they benefit only a subset of patients and biomarkers to guide immune checkpoint blockade (ICB) treatment choices are lacking. We designed this study to identify bl
Autor:
Ashley Marie Regazzi, Taha Merghoub, Tripti Tamhane, Colleen Anne Maher, Samuel Funt, Anne-Mette Bjerregaard, Hikmat Al-Ahmadie, Nana Haahr Overgaard, Jedd D. Wolchok, Amalie Kai Bentzen, Sine Reker Hadrup, Jeppe Sejerø Holm, Dean F. Bajorin, Jonathan E. Rosenberg, Morten Nielsen, Alexandra Snyder, James L. Reading, Phillip Wong
Publikováno v:
Journal of Clinical Oncology. 38:3075-3075
3075 Background: Proliferation of CD8 T cells can be detected in the blood of cancer patients (pts) following a single dose of immune checkpoint blockade (ICB) and tends to be more robust in responding pts. Furthermore, tumor mutational burden (TMB)
Autor:
Mark J. Bluth, Phillip Wong, Grace Hettich, Niamh M. Keegan, Jessica M. Clement, Samuel Funt, Brooke Elizabeth Kania, Gopa Iyer, Dean F. Bajorin, Etay Ziv, Jonathan E. Rosenberg, Katherine S. Panageas, Asia S. McCoy, Jedd D. Wolchok, Colleen Anne Maher, Suresh G. Nair Md, Margaret K. Callahan
Publikováno v:
Journal of Clinical Oncology. 37:481-481
481 Background: Overcoming resistance to anti-PD-1 therapy in UC patients (pts) is of major interest given the modest single agent response rates for pts with mUC. Herein we report the outcome of combined NIVO and IPI in pts who progressed on single
Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade
Autor:
Aya Haggiagi, Margaret K. Callahan, Yelena Shames, Rachna Malani, Katherine S. Panageas, Samuel Briggs, Colleen Anne Maher, Jessica Flynn, Jenessa Holder, Jessica A. Wilcox, Bianca Santomasso
Publikováno v:
Journal of Clinical Oncology. 36:3084-3084
3084Background: Neurologic irAEs are uncommon but potentially fatal toxicities of immune checkpoint blockade (ICB). Their incidence, clinical and pathologic features, and association with therapy r...
Autor:
Patrick Schöffski, S-H.I. Ou, Ashok Kumar Gupta, Joyce M Antal, Keith Steele, Ani Sarkis Balmanoukian, Neil H. Segal, Jared Weiss, Samir N. Khleif, Erminia Massarelli, Xiaoping Jin, Dan P. Zandberg, S.J. Antonia, Julie R. Brahmer, Christophe Massard, Marlon Rebelatto, Anna Spreafico, Colleen Anne Maher
Publikováno v:
Annals of Oncology. 27:vi328